Monroe Capital increased ProPharma Group’s credit facility to support the company’s acquisition of Xendo Holding.
Based in the Netherlands, Xendo provides compliance consulting, engineering and technical support, regulatory affairs and pharmacovigilance services to the (bio)pharmaceutical, medical device and healthcare industries.
ProPharma is an existing portfolio company of Linden Capital Partners.
The acquisition expands ProPharma’s geographic coverage for compliance consulting services to include Europe and adds additional high-value regulatory affairs and pharmacovigilance services, making ProPharma a single-source independent provider.
